Home -> Law Blog Directory -> Corporate & Securities Law Blogs -> OverRegd - Securities Regulation and Litigation Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate & Securities Law
: OverRegd - Securities Regulation and Litigation BlogSEC reveals "Top 10 Compliance Issues for 2008" at SIFMA Conference
Commissioner Lori Richards revealed the SEC’s “Top 10 Compliance Issues for 2008” during the general session at the 40th annual SIFMA national conference yesterday in
- Valuations.
- Firm controls over non-public information. In particular, the SEC is interested in whether the firm has identified the type and sources of non-public information to which its privy, and whether the firm has implemented and properly tested procedures for protecting that information.
- Retail sales practices – with an emphasis on protecting seniors.
- Supervision.
- Net capital/internal controls (which will receive increased focus given recent developments). Ms. Richards noted that 20% of the exams last year uncovered errors in net capital calculation.
- Trading.
- Fixed Income.
- Rating agencies.
- Conflicts of interest. The “hot list” for this area includes payments by advisors to broker dealers to appear on “recommended advisor lists,” and broker-dealers who sell interests in affiliated hedge funds.
- Anti-money laundering.
- Information/account security (refusing to be limited to just 10 areas, Ms. Richard actually named 11 key areas of scrutiny for 2008). The SEC is particularly interested in whether broker-dealers have adequate control over their customers’ assets and information, and what controls broker-dealers adopt when they outsource regulating activities. According to Ms. Richards, the SEC will focus on midsized firms this year.
Full post as published by OverRegd - Securities Regulation and Litigation Blog on April 02, 2008 (boomark / email).
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
FDA Issues Safety Warning About Valproic Acid and Divalproex Sodium
Valproic Acid and Divalproex Sodium FDA Issues Safety Warning About Risk for Birth Defects
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
FDA Issues Update on Safety Review Orlistat
Orlistat FDA Issues Update on Safety Review
FDA Issues Warning about Promethazine Hydrochloride Injection
Promethazine Hydrochloride Injection FDA issues warning
Honda Issues Massive Recalls in US and Canada
Honda Issues Massive Recalls in US and Canada

SEC Reveals Top 10 Compliance Issues for Investment Advisers
SEC Reveals Top 10 Compliance Issues for Investment Advisers
SEC's Richards Speaks on Examinations
FINRA, NASAA and SIFMA Present Testimony on ARS
SIFMA Files Comments on Mutual Fund Reform
Legal News - LexBlogosphere: 4/2/08







